• This invention relates to a 24 hour extended release dosage formulation and unit dosage form thereof of venlafaxine hydrochloride, an antidepressant, which provides better control of blood plasma levels than conventional tablet formulations which must be administered two or more times a day and further provides a lower incidence of nausea and vomiting than the conventional tablets. (gc.ca)
  • Zoetis Services LLC owns an invention patent, No. ZL200780048424.3, which relates to a vaccine for treating canine diseases. (managingip.com)
  • The present invention relates to oral dosage forms containing, as active ingredients, the biologically active proteins, granulocyte colony stimulating factor (G-CSF) and erythropoietin (EPO). (patenthub.cn)
  • The present invention relates to pyrazolopyrimidinone derivatives of che following formula 1, their preparation method and pharmaceutical compositions containing the said derivatives. (allindianpatents.com)
  • The invention relates to the chemical and pharmaceutical industry and concerns capsules with a powder pharmaceutical inhalation composition for the autoimmune diseases treatment. (rudn.ru)
  • The present invention relates to an abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N and to a process for the production thereof. (patsnap.com)
  • The present invention relates to antibodies or fragments thereof that specifically bind FcgammaRIIB, particularly human FcgammaRIIB, with greater affinity than said antibodies or fragments thereof bind FcgammaRIIA, particularly human FcgammaRIIA. (patsnap.com)
  • [0001] The present invention relates to the use of erythritol as a stable soluble filler in spray-dried pharmaceutical compositions and, in particular, to novel compositions comprising eythritol as excipient and the NK 3 receptor antagonist talnetant. (patentsencyclopedia.com)
  • The collegial panel opined that the language attests that claim 1 is not a mere feature of the drug administration method but a feature that would indirectly affect the product's preparation, suggesting that the product is a combination of two dosage forms, namely the injection formulation and the oral formulation, and their respective excipients thereof. (managingip.com)
  • The present invention further discloses a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or a pharmaceutically acceptable salt thereof, and lansoprazole, or a pharmaceutically acceptable salt thereof. (quickcompany.in)
  • The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. (justia.com)
  • These pharmaceutical dosage forms are exclusively rapid-release pharmaceutical compositions. (justia.com)
  • This invention includes pharmaceutical compositions, methods and kits for the treatment or diagnosis of a malignant tumors, including brain tumors, and diseases or disorders characterized by abnormal brain tissue. (patsnap.com)
  • The present invention is furthermore directed to a method of lyophilization using the mannose-containing solution, to pharmaceutical compositions, vaccines, kits, first and second medical uses applying such a mannose-containing solution and/or a nucleic acid (sequence) lyophilized or resuspended with such a solution. (patsnap.com)
  • The present invention provides systems, methods, and compositions for targeted delivery of nanoparticles and/or agents to tissues, cells, and/or subcellular locales. (patsnap.com)
  • The present invention is directed to pharmaceutical compositions that provide for the coordinated release of a lansoprazole and a naproxen. (quickcompany.in)
  • Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed. (patsnap.com)
  • Today, Freedom To Operate (FTO) announced it has filed requests for reconsideration [ PRG2022-00012 & PRG2022-00018 ] with the U.S. Patent Trial and Appeal Board (PTAB) in regard to its denials of FTO's petitions for Post Grant Review of Compass Pathways's Patents No. 10,947,257 and 10,954,259 directed to compositions and oral dosage forms containing its "Polymorph A" of psilocybin. (freedomtooperate.org)
  • Other aspects of the invention include: - an oral dosage form in the form of a capsule which comprises: 1) pomalidomide at an amount of 0. (caisouthern.com)
  • The tablet of the present invention comprises two active ingredients comprising two oral hypoglycemic agents: one phase with a sulphonylurea, such as immediate release Glimepiride and second phase with a biguanide, such as extended release Metformin hydrochloride (Metformin HCL). (ijpsr.com)
  • An independent claim comprises of vital elements of the invention. (indiafilings.com)
  • While the invention comprises, whatever elements trail these verbs, it could also include other, different elements. (indiafilings.com)
  • The present invention is directed to pharmaceutical solid, oral dosage forms which exhibit a modified release profile. (justia.com)
  • In the present patent embodiment, the combination of injection and oral dosage forms does indeed produce a good immunological effect, and the substantial contribution of the invention is the combination of the injection and oral dosage forms. (managingip.com)
  • Degradation problem under the resistance generation that the long-term use of furans worm hydrazides list agent may bring, the drug effect, the Pesticidal combination that the present invention proposes contains two kinds of active components of A, B, and an amount of surfactant and carrier. (google.com)
  • The oral drug preparations provided by the present invention avoid inactivation of the principal ingredient during the process of pharmaceutical manufacturing and display enhanced absorption of the ingredient from the intestinal tract, particularly as a result of the addition of fatty acid(s) to the drug composition. (patenthub.cn)
  • As such, oral dosage forms of the present invention can allow for dosage reductions, facilitate accurate dose control, and increase the practical usefulness of the bioactive proteins. (patenthub.cn)
  • The present invention provides lipid-based formulations for delivering, e.g., introducing, nucleic acid-lipid particles comprising an interference RNA molecule to a cell, and assays for optimizing the delivery efficiency of such lipid-based formulations. (patsnap.com)
  • The present invention is directed to (the use of) a solution containing at least one nucleic acid (sequence) and free mannose for lyophilization, transfection and/or injection, particularly of RNA and mRNA. (patsnap.com)
  • The present invention directed to drug dosage forms that release a Lansoprazole that raises the pH of a patient"s gastrointestinal tract, followed by a naproxen. (quickcompany.in)
  • This risk can have place until a staunch remission is achieved and be present spontaneously pending the sail as respects therapy specifically inflooding the early stages of remission primrose-colored when the dosage is assimilated. (archiviopeschiera.it)
  • The present invention provides a method of affecting physiological disorders by stimulating a specific location along the sympathetic nerve chain. (patsnap.com)
  • As noted in the letter sent to Compass, FTO underwrote ground-breaking research that enabled the quantification of particular polymorphic forms of crystalline psilocybin present in historical samples. (freedomtooperate.org)
  • The present invention is directed to a pharmaceutical composition in the form of a capsule with increased bioavailability as well as the process for obtaining said composition. (ijpsr.com)
  • singularity rather than totality, which has been criticized by other authors, his influence on The history of childcare and children's demystifying abstract natural children is healthcare forms part of the processes of organizing undeniable4. (bvsalud.org)
  • The invention is particularly suitable for once-a-day solid oral pharmaceutical dosage forms in which the active ingredient is memantine, releasing a therapeutically effective amount of the active ingredient over an extended time period. (justia.com)
  • Pharmacy profession is the art and science of discovery / invention of molecules with medicinal value, preparation of suitable dosage forms for administration of drugs in man and animals and their quality control. (edu.in)
  • With a broad expertise in the field of solid dosage forms, Dr. Thomas Kipping provides a deep understanding of formulation development and process optimization in the complex area of solubility enhancement. (sigmaaldrich.com)
  • Experience in formulation of pharmaceutical dosage forms. (nucapsnanotechnology.com)
  • As to the three pre-AIA patents, the district court concluded that the invention was not "ready for patenting" prior to the critical date, in view of the fact that a full analysis of the results from the FDA's Phase III clinical trials for Helsinn's 0.25 mg palonosetron formulation were not complete as of the critical date. (venable.com)
  • Our patented invention, the Enabling Absorption Device (ENA) compares performance of any type of advanced drug formulation and correctly picks the top performer in vivo without need for animal experiments. (enphasys.se)
  • Enphasys cutting edge expertise in drug formulation optimization helps ensure the optimal dosage form is selected for clinical development faster and at lower cost. (enphasys.se)
  • The invention discloses a medicine for treating summerheat injuring lung and stomach summer fever in children and a preparation method of the medicine. (google.com)
  • The invention discloses an insecticidal composition containing furan tebufenozide and amide compounds. (google.com)
  • The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. (justia.com)
  • Modified release solid oral dosage forms permit the sustained release of the active ingredient over an extended period of time in an effort to maintain therapeutically effective plasma levels over similarly extended time intervals and/or to modify other pharmacokinetic properties of the active ingredient. (justia.com)
  • The desired reduction in dosing frequency, for example from administration twice a day to once a day, can be achieved by prolonging the therapeutically effective plasma levels through modified release of active ingredients from dosage forms. (justia.com)
  • I have a particular interest in in-body imaging of foods, beverages, dosage forms and formulations, intestinal fluid distribution and the development of medical devices and novel MRI tests for GI motility and transit. (nottingham.ac.uk)
  • Consequently, it is difficult to patent inventions involving a new dosage regimen in China. (managingip.com)
  • On November 10 2021, a petitioner launched an invalidity attack against the patent at issue, arguing that adjusting the vaccine dosage form, excipients, and other composition in so far as it adapts to different routes of administration is a conventional technical means in this field, which is common knowledge among technical personnel and is devoid of novelty. (managingip.com)
  • Taking into account various parameters - including the literal interpretation of claim 1, the material contribution of the invention, and the consensus of the parties over the scope of protection of the patent at issue - the CNIPA affirmed that claim 1, in its essence, protects a combination product. (managingip.com)
  • The patent at issue pertains to the improvement of a dosage regimen. (managingip.com)
  • With the Helsinn decision, the Federal Circuit clarified that, under the post-AIA version of 102(b), public disclosure of the existence of the sale of a patented item may suffice to invalidate patent under the on-sale bar, even if "the details of the invention" are not "publicly disclosed in the terms of sale. (venable.com)
  • Prior to the AIA, 102(b) barred patents for inventions that were "on sale in this country, more than one year prior to the date of the application for patent. (venable.com)
  • This published research can be used by researchers, patent examiners and others to reject unfounded claims and to fight back against anyone attempting to patent a polymorphic form of LSD and its salts. (freedomtooperate.org)
  • As has previously been brought to the attention of Compass via an open letter sent by FTO, "Hydrate A", the crystalline form of psilocybin on which this most recent patent claim rests, is well known in the prior art. (freedomtooperate.org)
  • If Compass was unaware of the prior art at the time they filed for this patent, they should now review the peer reviewed published science on the matter and disclaim their patents directed to polymorphic forms of psilocybin. (freedomtooperate.org)
  • Hence, Patent Attorney's works diligently towards the borders of the invention and making the right patent claim in a Patent application. (indiafilings.com)
  • The holder of a patent may prevent potential competitors from infringing the invention claimed, which may convey market exclusivity for up to 20 years from the date the patent application is filed (and sometimes longer if there are patent office or regulatory delays). (drugdiscoveryonline.com)
  • Proactively applying for patent rights, even where there is no intention to assert them, prevents someone else from seeking to claim the same invention. (drugdiscoveryonline.com)
  • To receive a patent, an invention must be new, useful, non-obvious, and directed to patent eligible subject matter. (drugdiscoveryonline.com)
  • Since its invention, several companies have filed patents for several preparations for treating different conditions. (pipelinepharma.com)
  • Upon passage of the AIA, however, the language of 102(b) was changed to bar patents for inventions that were "on sale, or otherwise available to the public before the effective filing date of the claimed invention" (emphasis added). (venable.com)
  • Given the potentially negative effect this and other questionable Compass patents will have on the accessibility and affordability of psilocybin treatments for a range of conditions, FTO renews its call for Compass to disclaim its patents purporting to claim crystalline forms of psilocybin and well-known medical uses of psilocybin or, at a minimum, publicly covenant that it will not attempt to enforce any claim based on them. (freedomtooperate.org)
  • The USPTO has issued patents related to cannabis inventions in many areas. (drugdiscoveryonline.com)
  • Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. (drugpatentwatch.com)
  • Immediate release solid dosage forms permit the release of most or all of the active ingredient over a short period of time, such as 60 minutes or less, and make rapid absorption of the drug possible. (justia.com)
  • Moreover, after dosing with dosage forms with modified active ingredient release, it is possible for side effects to be reduced through smoothing of the plasma level time curve. (justia.com)
  • By minimizing the peak-trough ratio, i.e. by avoiding high plasma active ingredient concentrations, which are frequently observed after administration of rapid-release pharmaceutical forms, the occurrence of unwanted side effects correlating with the concentration peaks can be reduced. (justia.com)
  • The water that has penetrated in then releases the active ingredient in dissolved or suspended form from one or more orifices in the shell via the osmotic pressure that develops. (justia.com)
  • The invention also provides methods of enhancing efficacy of a vaccine composition by administering the antibodies of the invention. (patsnap.com)
  • The invention will help expand the arsenal of controlled-release drugs for the depressive disorders, anxiety and adaptation disorders treatment in human. (rudn.ru)
  • This dosage form in the form bio-adhesive films with a high bioavailability of the peptide. (rudn.ru)
  • The last measurement should be at a time point where at least 80% of the drug is dissolved (Guidance for Industry, "Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations", Food and Drug Administration, CDER, September 1997, Page 17). (justia.com)
  • Adequate sampling should be performed, for example, at 1, 2 and 4 hours and every two hours thereafter until 80% of the drug is released (Guidance for Industry, SUPAC-MR: Modified Release Solid Oral Dosage Forms," Food and Drug Administration, CDER, September 1997, Page 6). (justia.com)
  • In China, dosage regimen is generally viewed as a feature of drug administration, which, in principle, does not have a limiting effect on the product. (managingip.com)
  • The invention expanded the arsenal of medicines that provide delivery of the drug to the blood in an unchanged form, for inhalation administration in the autoimmune diseases treatment. (rudn.ru)
  • The invention belongs to technical field of pesticide, relate to a kind of Pesticidal combination that contains furans worm hydrazides and amides compound. (google.com)
  • As to the technical features embodied in claims based on a dosage regimen - such as administration object, method, route, dose, and time interval - the EPO adopts a different approach from the CNIPA. (managingip.com)
  • To treat infections caused by ulcer-causing Helicobacter pylori bacterium, the recommended dose is 5 billion colony-forming units, daily in addition to normal therapy. (pipelinepharma.com)
  • 3. Most production of medicines in the Region is limited to compounding and packaging, repacking, and processing bulk medicines into dosage forms using imported raw materials. (who.int)
  • The EPO explicitly recognises the patentability of use claims that are limited to a dosage regimen, whereas the CNIPA is of the opinion that the distinguishing features of an administration process cannot be used to establish novelty in a use claim. (managingip.com)
  • 3. Since then, applicants have been allowed to claim inventions relating to second medical uses using either the new, direct second medical use claim format, the Swiss-type format, or both, pending guidance from the UK courts and/or the EPO Boards of Appeal. (blogspot.com)
  • that applicants may no longer claim second medical use inventions in the Swiss format. (blogspot.com)
  • 14. A dosage form as claimed in claim 13 which is for oral administration. (patentsencyclopedia.com)
  • 15. A dosage form as claimed in claim 13 which is a capsule or a tablet. (patentsencyclopedia.com)
  • If this part of the claim speaks about a pharmaceutical theory, the claim is often analysed based on the body of the claim and it is patented based on the invention types. (indiafilings.com)
  • In invalidation decision No. 54827, the CNIPA set forth the reasoning and criteria in assessing novelty regarding product claims incorporating the technical features of a dosage regimen in the field of medicine. (managingip.com)
  • The reason why the CNIPA finds a technical feature of a dosage regimen has a limiting effect could be boiled down to the language employed in drafting the claims. (managingip.com)
  • 5. Subsequent to the decision of the Enlarged Board in G 02/08, only second medical use claims of the form "substance X for use in the treatment of disease Y" will be allowed. (blogspot.com)
  • Claims are set with a boundary of the invention. (indiafilings.com)
  • This risk can be located until a undifferentiated remission is achieved and occur spontaneously throughout the course apropos of ward, especially by the antiquated stages of remission or at which the dosage is changed. (archiviopeschiera.it)
  • It might be explanation of the invention or stages of invention. (indiafilings.com)
  • A modified-release pharmaceutical form should therefore be developed. (justia.com)
  • Both agreements were publicly disclosed before the critical date in MGI's Form 8-K filing with the SEC, with two exceptions: the price terms and the 0.25 mg and 0.75 mg dosage strengths were not disclosed. (venable.com)
  • The Ministry of Economic Development and Trade of Ukraine developed a (draft Law on Introduction of Amendments to Certain Legislative Acts of Ukraine Regarding the Improvement of Protection of Inventions and Useful Models, called to somehow stem the tide of "patenting" in Ukraine. (attorneys.ua)
  • Each annular element includes a plurality of struts and apices connected to form an annular configuration. (patsnap.com)
  • In the pharmaceutical field, there are inventions that address newly discovered dosage regimens for known drugs, such as new dosage or administration intervals, rather than new indications. (managingip.com)
  • 1. This Practice Notice sets out the practice of the Intellectual Property Office on the way in which inventions concerning a specific medical use of a substance or composition ("second medical use") may be claimed, in the light of the recent EPO Enlarged Board of Appeal decision in G 02/08 ABBOTT RESPIRATORY/Dosage regime . (blogspot.com)
  • Although devices and methods of the invention may be used to ablate epicardial tissue to treat atrial fibrillation, they may also be used in veterinary or research contexts, to treat various heart conditions other than atrial fibrillation and/or to ablate cardiac tissue other than the epicardium. (patsnap.com)
  • Before the EPO parameters are defined as features which are based on directly measurable properties or combinations of several variables in the form of formulae. (jakemp.com)
  • In 1859, workers operating the United States's first oil rigs noticed a paraffin-like material forming on rigs in the course of investigating malfunctions. (wikipedia.org)
  • His invention, vacuum compression molding (VCM), can prepare extrusion-like samples with a few mg of material. (sigmaaldrich.com)